🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 22 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/07/2004 12,06 12,48 11,94 12,00 -0,50% 4,48% 24.700
20/07/2004 12,66 12,72 11,88 12,06 +0,00% 6,64% 23.533
19/07/2004 12,06 12,42 11,88 12,06 -1,47% 4,48% 29.583
16/07/2004 12,36 12,60 12,12 12,24 -0,97% 3,88% 19.367
15/07/2004 12,48 12,72 12,30 12,36 -1,44% 3,37% 19.567
14/07/2004 12,54 12,84 12,42 12,54 -2,79% 3,35% 12.783
13/07/2004 12,54 12,96 12,42 12,90 +3,37% 4,31% 13.067
12/07/2004 12,78 12,96 12,42 12,48 -2,35% 4,23% 20.583
09/07/2004 13,20 13,50 12,78 12,78 -0,47% 5,45% 17.933
08/07/2004 13,44 13,56 12,84 12,84 -4,04% 5,36% 30.050
07/07/2004 13,32 13,38 12,90 13,38 +3,72% 3,60% 29.867
06/07/2004 13,50 13,62 12,90 12,90 -4,44% 5,33% 26.917
02/07/2004 13,74 13,92 13,50 13,50 -1,32% 3,06% 25.067
01/07/2004 14,64 14,76 13,50 13,68 -5,00% 8,61% 49.100
30/06/2004 14,28 14,70 14,22 14,40 -0,83% 3,36% 32.017
29/06/2004 14,58 14,70 13,80 14,52 +2,54% 6,17% 35.750
28/06/2004 14,88 15,00 13,80 14,16 +0,00% 8,06% 80.850
25/06/2004 14,88 17,10 13,80 14,16 -3,28% 22,18% 322.317
24/06/2004 14,40 15,00 13,26 14,64 +20,79% 12,08% 396.967
23/06/2004 12,48 12,48 11,76 12,12 +0,00% 5,77% 69.400
22/06/2004 12,24 12,48 11,46 12,12 -0,98% 8,33% 47.633
21/06/2004 12,54 13,08 12,00 12,24 -4,67% 8,61% 66.283
18/06/2004 12,60 13,14 12,00 12,84 -2,28% 9,05% 54.000
17/06/2004 12,90 13,14 12,54 13,14 +2,34% 4,65% 39.517
16/06/2004 12,78 13,14 12,30 12,84 +0,00% 6,57% 83.933
15/06/2004 13,20 13,38 12,72 12,84 -3,17% 5,00% 28.883
14/06/2004 12,96 13,44 12,84 13,26 -0,45% 4,63% 29.000
10/06/2004 14,16 14,16 13,20 13,32 +0,00% 6,78% 27.767
09/06/2004 14,04 14,04 13,32 13,32 -3,90% 5,13% 31.383
08/06/2004 14,16 14,16 13,38 13,86 -1,28% 5,51% 27.483